Literature DB >> 30905439

Comparison of the h-indices of the editorial board members of seven ophthalmic subspecialty journals.

H Bayramlar1, H Uslu1, O F Bayramlar2, R Karadag3.   

Abstract

PURPOSE: To investigate and compare the h-indices of the editorial board members of ophthalmic subspecialty journals. STUDY
DESIGN: Descriptive Cross Sectional Research.
METHODS: Bibliometric indices were calculated for the editorial board members of seven ophthalmic subspecialty journals. Correlations between the median h-indexes and journal impact factors (JIF), average citations per article and JIF, and publication count and JIF were analyzed.
RESULTS: The median h-indices of the board members of Retina, Journal of Glaucoma, Journal of Cataract and Refractive Surgery, Cornea, Ophthalmic Plastic and Reconstructive Surgery, Journal of Neuroophthalmology and Journal of the American Academy of Pediatric Ophthalmology and Strabismus (J AAPOS) were 34, 26, 23, 17, 15, 14 and 13, respectively. H-indices and publication count were correlated with JIF (P<0.05, for each).
CONCLUSION: The board members of Retina have the highest h-index and average citations per article, and J AAPOS have the least. These data provide useful benchmarks for comparison of the various subspecialty areas in ophthalmology.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Comité de rédaction; Editorial Board; H-index; Indice h; Journaux surspécialisés ophtalmologiques; Ophtalmologie; Ophthalmologic subspecialty journals; Ophthalmology; Web of Science

Mesh:

Year:  2019        PMID: 30905439     DOI: 10.1016/j.jfo.2018.10.008

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  1 in total

1.  Predicting article citations using data from 100 top-cited publications in the field of Psoriasis Vulgaris and biological agents (PVBA) since 1991: A bibliometric analysis.

Authors:  Chieh-Hsun Chen; Tsair-Wei Chien; Sam Yu-Chieh Ho; Feng-Jie Lai
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.